Reported 12,489 shares, up 11,352 (998.4%) from the prior quarter.
Reported value 1713.0%; share count 998.4% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2023-09-30 | 5821 |
| 2023-12-31 | 105532 |
| 2024-03-31 | 129763 |
| 2024-06-30 | 10885 |
| 2024-09-30 | 5232 |
| 2024-12-31 | 0 |
| 2025-03-31 | 13033 |
| 2025-06-30 | 306987 |
| 2025-09-30 | 83593 |
| 2025-12-31 | 2549481 |
| 2026-03-31 | 1575636 |
| 2026-06-30 | 1828255 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q2 2026 | Added | 401,814 | +7,905 (2.0%) | < 0.01% | $1,828,255 | 2026-08-13 | |
| Q1 2026 | Added | 393,909 | +28,654 (7.8%) | < 0.01% | $1,575,636 | 2026-05-15 | |
| Q4 2025 | Added | 365,255 | +347,278 (1931.8%) | < 0.01% | $2,549,481 | 2026-02-13 | |
| Q3 2025 | Reduced | 17,977 | -38,351 (-68.1%) | < 0.01% | $83,593 | 2025-11-14 | |
| Q2 2025 | Added | 56,328 | +53,967 (2285.8%) | < 0.01% | $306,987 | 2025-08-15 | |
| Q1 2025 | New | 2,361 | +2,361 (0.0%) | < 0.01% | $13,033 | 2025-05-15 | |
| Q4 2024 | Reduced | 0 | -1,135 (-100.0%) | 0 | $0 | 2025-02-14 | |
| Q3 2024 | Reduced | 1,135 | -837 (-42.4%) | < 0.01% | $5,232 | 2024-11-14 | |
| Q2 2024 | Reduced | 1,972 | -11,337 (-85.2%) | < 0.01% | $10,885 | 2024-08-14 | |
| Q1 2024 | Added | 13,309 | +820 (6.6%) | < 0.01% | $129,763 | 2024-05-15 | |
| Q4 2023 | Added | 12,489 | +11,352 (998.4%) | < 0.01% | $105,532 | 2024-02-13 | |
| Q3 2023 | New | 1,137 | +1,137 (0.0%) | < 0.01% | $5,821 | 2023-11-15 |
Who else reported the position
21 managers reported TRISALUS LIFE SCIENCES INC for Q4 2023.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | New | 165,136 | +165,136 | < 0.01% | $1,395,399 | 1 qtr |
| GEODE CAPITAL MANAGEMENT LLC | Added | 125,762 | +108,523 | < 0.01% | $1,063,067 | 2 qtrs |
| HC Advisors LLC | New | 101,736 | +101,736 | 0.48% | $859,669 | 1 qtr |
| Connecticut Wealth Management LLC | Unchanged | 57,188 | 0 | 0.03% | $483,239 | 2 qtrs |
| HRT FINANCIAL LP | New | 48,011 | +48,011 | < 0.01% | $405,000 | 1 qtr |
| Anson Capital Inc | Unchanged | 35,005 | 0 | 0.49% | $295,792 | 2 qtrs |
| WETHERBY ASSET MANAGEMENT INC | New | 34,950 | +34,950 | 0.02% | $295,328 | 1 qtr |
| Tyche Wealth Partners LLC | New | 26,664 | +26,664 | 0.05% | $225,311 | 1 qtr |
| NORTHERN TRUST CORPORATION | New | 18,190 | +18,190 | < 0.01% | $153,706 | 1 qtr |
| UBS Group AG | Reduced | 16,815 | -8,117 | < 0.01% | $142,087 | 2 qtrs |
Filing details and methodology As reported
- Report period
- December 31, 2023
- Filed
- February 13, 2024
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 0
- Shared
- 0
- None
- 12,489
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.